Literature DB >> 33356221

Exploring the pH-Dependent Structure-Dynamics-Function Relationship of Human Renin.

Shuhua Ma1, Jack A Henderson2, Jana Shen2.   

Abstract

Renin is a pepsin-like aspartyl protease and an important drug target for the treatment of hypertension; despite three decades' research, its pH-dependent structure-function relationship remains poorly understood. Here, we employed continuous constant pH molecular dynamics (CpHMD) simulations to decipher the acid/base roles of renin's catalytic dyad and the conformational dynamics of the flap, which is a common structural feature among aspartyl proteases. The calculated pKa's suggest that catalytic Asp38 and Asp226 serve as the general base and acid, respectively, in agreement with experiment and supporting the hypothesis that renin's neutral optimum pH is due to the substrate-induced pKa shifts of the aspartic dyad. The CpHMD data confirmed our previous hypothesis that hydrogen bond formation is the major determinant of the dyad pKa order. Additionally, our simulations showed that renin's flap remains open regardless of pH, although a Tyr-inhibited state is occasionally formed above pH 5. These findings are discussed in comparison to the related aspartyl proteases, including β-secretases 1 and 2, cathepsin D, and plasmepsin II. Our work represents a first step toward a systematic understanding of the pH-dependent structure-dynamics-function relationships of pepsin-like aspartyl proteases that play important roles in biology and human disease states.

Entities:  

Year:  2020        PMID: 33356221      PMCID: PMC7855609          DOI: 10.1021/acs.jcim.0c01201

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  42 in total

1.  Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets.

Authors:  Jürgen Maibaum; Stefan Stutz; Richard Göschke; Pascal Rigollier; Yasuchika Yamaguchi; Frédéric Cumin; Joseph Rahuel; Hans-Peter Baum; Nissim-Claude Cohen; Christian R Schnell; Walter Fuhrer; Markus G Gruetter; Walter Schilling; Jeanette M Wood
Journal:  J Med Chem       Date:  2007-09-08       Impact factor: 7.446

Review 2.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

3.  Predicting Catalytic Proton Donors and Nucleophiles in Enzymes: How Adding Dynamics Helps Elucidate the Structure-Function Relationships.

Authors:  Yandong Huang; Zhi Yue; Cheng-Chieh Tsai; Jack A Henderson; Jana Shen
Journal:  J Phys Chem Lett       Date:  2018-02-22       Impact factor: 6.475

4.  Roles of His9 (P2 subsite) and His13 (P3' subsite) in angiotensinogen for catalytic reaction of renin.

Authors:  A H M Nurun Nabi; Mohammad Nasir Uddin; Tsutomu Nakagawa; Takenori Orihashi; Akio Ebihara; Atsushi Iwasawa; Yukio Nakamura; Fumiaki Suzuki
Journal:  Int J Mol Med       Date:  2005-07       Impact factor: 4.101

5.  Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

Authors:  A M Silva; A Y Lee; S V Gulnik; P Maier; J Collins; T N Bhat; P J Collins; R E Cachau; K E Luker; I Y Gluzman; S E Francis; A Oksman; D E Goldberg; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Molecular dynamics studies on both bound and unbound renin protease.

Authors:  Natércia F Brás; Pedro A Fernandes; Maria J Ramos
Journal:  J Biomol Struct Dyn       Date:  2013-03-25

Review 7.  Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease.

Authors:  Jing Yuan; Shankar Venkatraman; Yajun Zheng; Brian M McKeever; Lawrence W Dillard; Suresh B Singh
Journal:  J Med Chem       Date:  2013-04-05       Impact factor: 7.446

8.  Recent development and application of constant pH molecular dynamics.

Authors:  Wei Chen; Brian H Morrow; Chuanyin Shi; Jana K Shen
Journal:  Mol Simul       Date:  2014-01-01       Impact factor: 2.178

9.  Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor.

Authors:  Yasuhiro Imaeda; Hidekazu Tokuhara; Yoshiyuki Fukase; Ray Kanagawa; Yumiko Kajimoto; Keiji Kusumoto; Mitsuyo Kondo; Gyorgy Snell; Craig A Behnke; Takanobu Kuroita
Journal:  ACS Med Chem Lett       Date:  2016-09-12       Impact factor: 4.345

10.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

View more
  3 in total

1.  Exploring the pH- and Ligand-Dependent Flap Dynamics of Malarial Plasmepsin II.

Authors:  Jack A Henderson; Jana Shen
Journal:  J Chem Inf Model       Date:  2021-12-29       Impact factor: 4.956

Review 2.  Pepsin-like aspartic proteases (PAPs) as model systems for combining biomolecular simulation with biophysical experiments.

Authors:  Soumendranath Bhakat
Journal:  RSC Adv       Date:  2021-03-17       Impact factor: 3.361

3.  Flap Dynamics in Pepsin-Like Aspartic Proteases: A Computational Perspective Using Plasmepsin-II and BACE-1 as Model Systems.

Authors:  Soumendranath Bhakat; Pär Söderhjelm
Journal:  J Chem Inf Model       Date:  2022-02-09       Impact factor: 4.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.